|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 7
2022
Hayden, P. J.; Roddie, C.; Bader, P.; Basak, G. W.; Bonig, H.; Bonini, C.; Chabannon, C.; Ciceri, F.; Corbacioglu, S.; Ellard, R.; Sanchez-Guijo, F.; Jaeger, U.; Hildebrandt, M.; Hudecek, M.; Kersten, M. J.; Koehl, U.; Kuball, J.; Mielke, S.; Mohty, M.; Murray, J.; Nagler, A.; Rees, J.; Rioufol, C.; Saccardi, R.; Snowden, J. A.; Styczynski, J.; Subklewe, M.; Thieblemont, C.; Topp, M.; Ispizua, A. U.; Chen, D.; Vrhovac, R.; Gribben, J. G.; Kroeger, N.; Einsele, H. und Yakoub-Agha, I
(2022):
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).
In: Annals of Oncology, Bd. 33, Nr. 3: S. 259-275
Buske, C.; Dreyling, M.; Alvarez-Larran, A.; Apperley, J.; Arcaini, L.; Besson, C.; Bullinger, L.; Corradini, P.; Della Porta, M. Giovanni; Dimopoulos, M.; D'Sa, S.; Eich, H. T.; Foa, R.; Ghia, P.; da Silva, M. G.; Gribben, J.; Hajek, R.; Harrison, C.; Heuser, M.; Kiesewetter, B.; Kiladjian, J. J.; Kroeger, N.; Moreau, P.; Passweg, J. R.; Peyvandi, F.; Rea, D.; Ribera, J.-M.; Robak, T.; San-Miguel, J. F.; Santini, V.; Sanz, G.; Sonneveld, P.; Lilienfeld-Toal, M. von; Wendtner, C.; Pentheroudakis, G. und Passamonti, F.
(2022):
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.
In: ESMO Open, Bd. 7, Nr. 2, 100403
2016
Heidenreich, S.; Ziagkos, D.; Biezen, A. van; Finke, J.; Platzbecker, U.; Niederwieser, D.; Einsele, H.; Bethge, W. A.; Schleuning, M.; Beelen, D. W.; Tischer, J.; Nagler, A.; Glass, B.; Maertens, J.; Richard, C.; Beguin, Y.; Sill, H.; Witte, T. de; Robin, M. und Kroeger, N.
(2016):
Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: Update of a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S510-S511
Malard, F.; Labopin, M.; Stuhler, G.; Bittenbring, J.; Ganser, A.; Tischer, J.; Michallet, M.; Kroeger, N.; Schmid, C.; Huynh, A.; Hallek, M.; Savani, B.; Mohty, M. und Nagler, A.
(2016):
Sequential intensified conditioning regimen allogeneic hematopoietic stem cell transplantation in adult patients with high-risk AML in complete remission: a survey from the ALWP of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S11-S11
Robin, M.; Porcher, R.; Lint, M. T. van; Ciceri, F.; Tisher, J.; Sanz, J.; Platzbecker, U.; Biezen, A. van; Kosker, L.; Blaise, D.; Velardi, A.; Peterson, E.; Stuhler, G.; Mufti, G.; Koc, Y.; Bethge, W.; Michallet, M.; Vigouroux, S.; Koenecke, C.; Beelen, D.; Yacoug-Agha, I.; Vitek, A.; Arcese, W.; Witte, T. de und Kroeger, N.
(2016):
Comparison of outcome after haplo-identical, HLA-mismatched unrelated donor and unrelated cord blood transplantation in patients with myelodysplastic syndrome (MDS) and secondary acute myeloblastic leukemia (sAML): an EBMT study.
In: Bone Marrow Transplantation, Bd. 51:
S73-S73
Gorkom, G. van; Gelder, M. van; Ziagkos, D.; Koster, L.; Koc, Y.; Lint, M. van; Ciceri, F.; Selleslag, D.; Blaise, D.; Foa, R.; Beelen, D.; Corradini, P.; Moreno, C.; Carlson, K.; Solano, C.; Müller, L. P.; Castagna, L.; Tischer, J.; Hilgendorf, I.; Hallek, M.; Bittenbring, J.; Theobald, M.; Schetelig, J. und Kroeger, N.
(2016):
Outcomes of mismatched related allogeneic stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S293-S294
Christopeit, M.; Tischer, J.; Schetelig, J.; Bornhäuser, M.; Uharek, L.; Wolff, D.; Holler, E.; Pfrepper, C.; Behre, G.; Niederwieser, D.; Kroeger, N.; Kobbe, G.; Weber, T.; Müller, L. P.; Rösler, W.; Klein, S.; Hausmann, A.; Beelen, D. W.; Bethge, W. und Schmid, C.
(2016):
Haploidentical second allogeneic hematopoietic stem cell transplantation for the treatment of acute leukemia relapse after first allo-HSCT: An updated retrospective registry analysis of 69 pts on behalf of the German Cooperative Transplant Group.
In: Oncology Research and Treatment, Bd. 39: S. 168